Blood Adult Stem Cell Expansion via Hematosphere Spheroid Culture
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for expanding blood adult stem cells in vitro face challenges such as limited supply, side effects from G-CSF mobilization, and difficulty in replicating the bone marrow environment using artificial substances, leading to inefficiencies in harvesting and maintaining pluripotency.
Innovation Solution
The method involves isolating mononuclear cells from blood, aggregating them in a three-dimensional structure in an ultra-low attach culture dish to form blood-born hematospheres, allowing for proliferation and dissociation into single cells while maintaining pluripotency, thereby expanding blood adult stem cells effectively.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Quantity of substance
If bone marrow harvesting is performed to obtain blood adult stem cells, then sufficient stem cells can be obtained for therapy, but harvesting difficulty and patient discomfort increase
Solution Approach 1:
The invention extracts blood adult stem cells from peripheral blood instead of harvesting from bone marrow. By using G-CSF to mobilize stem cells into peripheral blood and then isolating them from blood samples, the method avoids the invasive bone marrow harvesting procedure while obtaining sufficient stem cells for therapy.
Solution Approach 2:
The invention uses G-CSF as an intermediary substance to facilitate stem cell mobilization from bone marrow to peripheral blood. This mediator enables non-invasive collection of stem cells through blood draws, resolving the contradiction between obtaining sufficient cells and avoiding harvesting difficulty.
2Ease of operation
If G-CSF injection is used to mobilize stem cells into peripheral blood, then stem cell collection becomes easier, but side effects increase
Solution Approach 1:
The invention uses a lower, partial dose of G-CSF (5 µg/kg/day) compared to typical mobilization doses (10-20 µg/kg/day). This reduced dosage is sufficient to achieve stem cell mobilization into peripheral blood while minimizing the side effects associated with higher doses, thus resolving the contradiction between ease of collection and harmful effects.
3Ease of manufacture
If conventional two-dimensional culture methods are used to expand blood adult stem cells, then culture simplicity is maintained, but expansion efficiency and pluripotency maintenance are insufficient
Solution Approach 1:
The invention transitions from conventional two-dimensional monolayer culture to three-dimensional spheroid culture. By forming cell aggregates in suspension culture, the method creates a more physiologically relevant environment that enhances stem cell expansion efficiency and pluripotency maintenance while remaining relatively simple to implement.
Solution Approach 2:
The invention utilizes spheroidal cell aggregates instead of flat monolayers. The three-dimensional spherical structure provides improved nutrient diffusion, cell-cell interactions, and signaling environments that enhance stem cell proliferation and maintenance of pluripotency, directly addressing the limitation of conventional 2D culture methods.
4Productivity
If artificial bone marrow-mimic environments are created to expand blood adult stem cells, then in vitro expansion is achieved, but the complexity of replicating the native environment increases
Solution Approach 1:
The invention allows blood adult stem cells to self-organize into spheroid structures in suspension culture without requiring complex artificial bone marrow-mimic environments. The cells naturally form aggregates that create their own favorable microenvironment, eliminating the need for complicated extracellular matrix coatings, specialized substrates, or complex cytokine cocktails typically required for in vitro expansion.
Data Source
Figure 1
Figure 2
Figure 3
AI summary
The present invention relates to a technique of using monocytic blood cells to effectively culture and proliferate blood adult stem cells and progenitor cells that only exist in small quantities to effectively obtain large quantities of stem cells. According to the present invention, the limitation of being able to derive only small quantities of stem cells from blood can be overcome, and the pluripotency of stem cells can easily be obtained.